JLE

Epileptic Disorders

MENU

Burden of seizures and comorbidities in patients with epilepsy: a survey based on the tertiary hospital-based Epilepsy Syndrome Registry in Japan Volume 24, numéro 1, February 2022

  • [1] Hayashi S., Umeda T. 35 years of Japanese policy on rare diseases. Lancet. 2008;372:889-890. 9642
  • [2] Takemura S., Sone T. Research and development on intractable & rare diseases in Japan: contribution of the National Institute of Public Health to research program management. J Natl Inst Public Health. 2019;68:45-54. 1
  • [3] Feinstein A.R. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455-468. 7
  • [4] Saito T., Kada A., Ito N., Saito A.M., Inoue Y., Horibe K. Development of a rare disease registry: valuable lessons learned on how to build a sustainable disease registry. Jpn Pharmacol Ther. 2015;43:s58-65. s1
  • [5] Saito T., Saito A.M., Kondo S., Nagai K., Nishioka E., Horibe K. Computerization of clinical trial data management at the clinical research core hospital in Japan. Regulatory Science of Medical Products. 2015;5:61-71.
  • [6] Bureau M., Genton P., Dravet C.H., Delgado-Escueta A.V., Tassinari C.A., Thomas P. Epileptic syndromes in infancy. Childhood and adolescence. Montrouge: John Libbey Eurotext; 2012. 5 edth
  • [7] Epilepsydiagnosis.org. Diagnostic manual. International league against epilepsy. https://www.epilepsydiagnosis.org
  • [8] Scheffer I.E., Berkovic S., Capovilla G., Connolly M.B., French J., Guilhoto L. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:512-521. 4
  • [9] Ho N.T., Kroner B., Grinspan Z., Fureman B., Farrell K., Zhang J. Rare epilepsy network steering committee. Comorbidities of rare epilepsies: results from the rare epilepsy network. J Pediatr. 2018;203:249-258.e5.
  • [10] Shirozu H., Masuda H., Kameyama S. Repeat stereotactic radiofrequency thermocoagulation in patients with hypothalamic hamartoma and seizure recurrence. Epilepsia Open. 2020;5:107-120. 1
  • [11] Thorbecke R., Pfäfflin M. Social aspects of epilepsy and rehabilitation. Handb Clin Neurol. 2012;108:983-999.
  • [12] Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Hauser W.A., Mathern G. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069-1077.
  • [13] Japan intractable disease information center. https://www.nanbyou.or.jp